Cochrane Abstracts
Dapsone as an oral corticosteroid sparing agent for asthma: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dapsone as an Oral Corticosteroid Sparing Agent for Asthma: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438934/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma:_Cochrane_systematic_review.
Dapsone as an oral corticosteroid sparing agent for asthma: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438934/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma:_Cochrane_systematic_review. Accessed March 22, 2025.
Dapsone as an oral corticosteroid sparing agent for asthma: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438934/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma:_Cochrane_systematic_review
Dapsone as an Oral Corticosteroid Sparing Agent for Asthma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438934/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dapsone as an oral corticosteroid sparing agent for asthma: Cochrane systematic review
ID - 438934
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438934/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
